Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Clinical trial NCT07148050 · RECRUITING

Trial details

NCT number: NCT07148050
Sponsor: Seattle Children's Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor (Excluding CNS)Liver Cell Carcinoma Malignant Rhabdoid Tumor Yolk Sac Tumor Liposarcoma Rhabdomyosarcoma Embryonal Sarcoma of Liver Wilms Tumor Hepatocellular Carcinoma Hepatoblastoma

Start date: 2025-12-22
Primary completion: 2029-04-22
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.